In many cases of malignant melanoma, the effect of targeted treatment is lost over time. A research team has now discovered that a factor secreted by tumor cells is responsible for the resistance. These findings could pave the way for more effective therapies.
Quelle: ScienceDaily | Immunsystem
Titelbild/Grafik: ScienceDaily News
Kommentare und Fragen
Möchten Sie zu diesem Inhalt ein Kommentar abgeben oder haben Sie dazu eine Frage, dann machen Sie dies bitte immer auf der Herausgeberseite!
Weiteres von ScienceDaily | Allergy
- Serendipity reveals new method to fight cancer with T cells
- Light targets cells for death and triggers immune response with laser precision
- Mechanism of lupus pathogenesis unveiled
- The mechanism behind melanoma resistance to treatment
- Master autoimmune regulator gets by with a little help from its friends
- Tai Chi reduces risk of inflammatory disease, treats insomnia among breast cancer survivors
- Microrobot-packed pill shows promise for treating inflammatory bowel disease in mice
- A method to study immune cells offers hope for finding new disease treatments
- A new method for improving checkpoint inhibitor therapy for cancer
- Treatment for autoimmune disorder acts on balance of immune cell types
